These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11604597)

  • 1. New drug therapies for the pediatric rheumatic diseases.
    Bloom BJ
    Curr Opin Rheumatol; 2001 Sep; 13(5):410-4. PubMed ID: 11604597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of rheumatoid arthritis: old versus new therapies.
    Saravanan V; Hamilton J
    Expert Opin Pharmacother; 2002 Jul; 3(7):845-56. PubMed ID: 12083985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for the treatment of rheumatoid arthritis.
    Schuna AA; Megeff C
    Am J Health Syst Pharm; 2000 Feb; 57(3):225-34. PubMed ID: 10674776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Society for Rheumatic Therapy guest society symposium: recent therapeutic experiences with new generation drugs for inflammatory diseases.
    White B
    Inflamm Res; 2002 Feb; 51(2):73-5. PubMed ID: 11926314
    [No Abstract]   [Full Text] [Related]  

  • 5. Rheumatoid arthritis: developing pharmacological therapies.
    Misischia RJ; Moreland LW
    Expert Opin Investig Drugs; 2002 Jul; 11(7):927-35. PubMed ID: 12084003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
    ten Cate R; van Suijlekom-Smit LW; Brinkman DM; Bekkering WP; Jansen-van Wijngaarden CJ; Vossen JM
    Rheumatology (Oxford); 2002 Feb; 41(2):228-9. PubMed ID: 11886975
    [No Abstract]   [Full Text] [Related]  

  • 7. Current drug therapy for rheumatoid arthritis.
    Kawai S
    J Orthop Sci; 2003; 8(2):259-63. PubMed ID: 12665969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.
    Fleischmann R; Iqbal I; Nandeshwar P; Quiceno A
    Drug Saf; 2002; 25(3):173-97. PubMed ID: 11945114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
    Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
    Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the medical treatment of juvenile rheumatoid arthritis.
    Onel KB
    Curr Opin Pediatr; 2000 Feb; 12(1):72-5. PubMed ID: 10676778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biologics for treatment of juvenile idiopathic arthritis. Consensus statement of the 7th Wörlitzer Expertengespräche 2004 for the German Arbeitsgemeinschaft Kinder- und Jugendrheumatologie].
    Horneff G
    Z Rheumatol; 2006 Mar; 65(2):152-6, 158. PubMed ID: 16372138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.
    Culy CR; Keating GM
    Drugs; 2002; 62(17):2493-537. PubMed ID: 12421111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept improves active polyarticular juvenile rheumatoid arthritis.
    Martini A
    Clin Exp Rheumatol; 2001; 19(2):122-4. PubMed ID: 11326472
    [No Abstract]   [Full Text] [Related]  

  • 15. Radiologic Improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.
    Tse SM; Laxer RM; Babyn PS; Doria AS
    J Rheumatol; 2006 Jun; 33(6):1186-8. PubMed ID: 16755667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of juvenile arthritis.
    Hamilton J; Capell H
    Expert Opin Pharmacother; 2001 Jul; 2(7):1085-92. PubMed ID: 11583059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
    Mori M; Takei S; Imagawa T; Imanaka H; Nerome Y; Kurosawa R; Kawano Y; Yokota S; Sugiyama N; Yuasa H; Fletcher T; Wajdula JS
    Mod Rheumatol; 2011 Dec; 21(6):572-8. PubMed ID: 21479889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of etanercept in treatment of juvenile idiopathic arthritis and adult onset still disease].
    Lewicki M; Kotulska A; Kucharz EJ
    Pol Arch Med Wewn; 2005 May; 113(5):505-8. PubMed ID: 16479836
    [No Abstract]   [Full Text] [Related]  

  • 19. Arthritis. Timely treatments for an ageless disease.
    Lewis C
    FDA Consum; 2000; 34(3):27-9, 31-3. PubMed ID: 11521251
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.